Sigachi Industries shares surged 20% on February 4 after the company announced that Telangana High Court has granted bail to its managing director and CEO Amit Raj Sinha in connection to a massive explosion at its factory last year that killed around 40 people. According to reports from Reuters, the shares jumped as much as 20% on the day and were last trading 15% higher, marking their best day since September. The rally came as a significant relief for investors who have seen the stock experience substantial volatility following the tragic incident.
The explosion occurred on June 30 last year at the company's pharma factory located in Telangana's Pashamylaram in Sangareddy, during normal operations. As reported by Reuters, Sinha was remanded in late-December as part of an investigation into the fire at Sigachi's chemical unit. One of the chemical reactors exploded, resulting in loss of lives and several injuries. The incident damaged ancillary equipment and civil structures within the facility, with the company stating that operations at the plant would be temporarily paused for an estimated 90 days to facilitate replacement and restoration of affected equipment and structures.
The affected plant represents a significant portion of Sigachi Industries' manufacturing capabilities, contributing approximately 6,000 MTPA out of total operating capacity of 21,700 MTPA. According to the company's exchange filing reported by Moneycontrol, this unit is one of three manufacturing facilities for Microcrystalline Cellulose (MCC) production. The other two plants located in Gujarat continue to operate normally, helping maintain overall production capacity. However, the disaster has exposed critical safety lapses, with the Telangana Fire Department reporting inadequate safety measures at the plant.
Sigachi Industries shares have experienced significant volatility since the incident, falling around 50% in the past one year after hitting a 52-week high of ₹59.59 apiece in June last year. As reported by Moneycontrol, the stock tumbled more than 68% in around eight months to hit a fresh 52-week low of ₹18.92 apiece day before yesterday. The company's current market capitalization stands at over ₹900 crore, with its Price-to-Earnings ratio of approximately 14.8x appearing lower than many specialty pharmaceutical peers like Gland Pharma (36.03x) or Cipla (23.18x).
Despite the positive market reaction to the bail development, analysts maintain a cautious outlook on Sigachi Industries. MarketsMOJO maintains a 'Strong Sell' rating as of January 12, 2026, citing deteriorating profitability, declining net sales, low return on capital employed (ROCE) of 4.37%, and significant promoter share pledging of 40.32% as of December 2025. The company's debt-equity ratio has risen to 2.86, signalling increased leverage and financial risk. The immediate focus for investors remains on the company's ability to implement robust safety protocols and achieve operational stability, critical factors that the current stock price rally does not adequately reflect.
